The Pharmaceutical Market: Indonesia

Date: January 31, 2013
Pages: 117
Price:
US$ 1,295.00
License [?]:
Publisher: Espicom Business Intelligence
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: P4C7A6F50DDEN
Leaflet:

Download PDF Leaflet

The Pharmaceutical Market: Indonesia
OVERVIEW OF THE PHARMACEUTICAL MARKET IN INDONESIA

Indonesia's new goal to establish universal healthcare coverage by 2019 rather than 2014 is more feasible given that the programme will be rolled out in phases. We continue to see universal healthcare coverage as a key theme in Asia, although poor governance in several countries across the region will delayitsimplementation. Despite this, pharmaceutical firms will continue to enjoy strong growth in the region due to the expanding, increasingly ageing and affluent population, which will boost volume demand for pharmaceuticals as well as medical services across the board.

Headline Expenditure Projections

Pharmaceuticals: IDR53,041bn (US$6.04bn) in 2011 to IDR58,657bn (US$6.25bn) in 2012; +10.6% growth in local currency terms and +3.5% in US dollar terms. Local currency forecast broadly unchanged from previous quarter.

Healthcare: IDR195,355bn (US$22.26bn) in 2011 to IDR223,454bn (US$23.82bn) in 2012; +14.4% growth in local currency terms and +7.0% in US dollar terms. Local currency forecast unchanged from previous quarter.

Medical Devices: IDR5,721bn (US$652mn) in 2011 to IDR6,282bn (US$670mn) in 2012; +9.8% growth in local currency terms and +2.7% in US dollar terms. Local currency forecast broadly unchanged from previous quarter.

Competitive Landscape

The Competitive Landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
EXECUTIVE SUMMARY

SWOT ANALYSIS

    Indonesia Pharmaceutical And Healthcare Industry SWOT
    Indonesia Political SWOT
    Indonesia Economic SWOT
    Indonesia Business Environment SWOT

PHARMACEUTICAL RISK/REWARD RATINGS

    Table: Asia Pacific Pharmaceutical And Healthcare Risk/Reward Ratings, Q113
    Rewards
    Risks

MARKET SUMMARY – INDONESIA

REGULATORY REGIME

    Table: New Drug Approvals, 2010
    Pharmaceutical Advertising
    Regional Harmonisation
    Intellectual Property Issues
    Compulsory Licensing
    Counterfeit Drugs
    Generic Drug Legislation
    Labelling Requirements
    Free Trade Agreements
    Pricing Regime
    Reimbursement Regime

INDUSTRY TRENDS AND DEVELOPMENTS

    Epidemiology
    Non-Communicable Diseases
    Communicable Diseases
    Public Health Developments
    Table: UN Millennium Development Goals For Indonesia
    Healthcare System
    Health Insurance
    Healthcare System Reform
    Research & Development
    Clinical Trials
    Herbal Medicines
    Medical Devices

INDUSTRY FORECAST SCENARIO

    Pharmaceutical Market Forecast
    Table: Pharmaceutical Sales, 2008-2016
    Healthcare Market Forecast
    Table: Overall Healthcare Expenditure, 2008-2016
    Table: Government Healthcare Expenditure, 2008-2016
    Table: Private Healthcare Expenditure, 2008-2016
    Key Growth Factors – Macroeconomic
    Indonesia Pharmaceuticals & Healthcare Report Q1 2013
    TABLE: Indonesia Long-Term Macroeconomic Forecasts
    Prescription Drug Market Forecast
    Table: Prescription Drug Sales, 2008-2016

PATENTED DRUG MARKET FORECAST

    Table: Patented Drug Sales, 2008-2016
    Generic Drug Market Forecast
    Table: Generic Drug Sales, 2008-2016
    OTC Medicine Market Forecast
    Table: OTC Medicine Sales, 2008-2016
    Table: OTC Medicine Sales, 2004-2010
    Pharmaceutical Trade Forecast
    Table: Pharmaceutical Trade, 2008-2016
    Medical Device Market Forecast
    Table: Medical Device Sales, 2008-2016
    Other Healthcare Data
    Key Risks To BMI’s Forecast Scenario

COMPETITIVE LANDSCAPE

    Pharmaceutical Industry
    Table: Pharmaceutical Manufacturers By Region, 2000-2010
    Table: Selected List Of Pharmaceutical Business Areas With Restricted Conditions
    Table: Top-10 Pharmaceutical Companies According To Market Capitalisation
    Domestic Industry
    Foreign Industry
    Table: Members Of The International Pharmaceutical Manufacturers Group (IPMG)
    Recent Pharmaceutical Sector Developments
    Pharmaceutical Wholesaling
    Table: Pharmaceutical Wholesalers By Region, 2000-2010
    Pharmaceutical Retail
    Table: Pharmacies By Region, 2000-2010
    Table: Drug Stores By Region, 2001-2010

COMPANY PROFILES

    Domestic Companies
    Soho Group
    Darya-Varia Group
    PT Kalbe Farma
    PT Bio Farma
    Kimia Farma
    Combiphar PT
    Multinational Companies
    Sanofi
    Pfizer
    Novartis
    GlaxoSmithKline
    Merck & Co
    Bayer
    Merck Group

DEMOGRAPHIC OUTLOOK

    Table: Population By Age Group, 1990-2020 (‘000)
  Indonesia Pharmaceuticals & Healthcare Report Q1 2013
    Table: Population By Age Group, 1990-2020 (% of total)
    Table: Key Population Ratios, 1990-2020
    Table: Rural/Urban Population Split, 1990-2020

BMI METHODOLOGY

    How We Generate Our Pharmaceutical Industry Forecasts
    Pharmaceutical Risk/Reward Ratings Methodology
    Ratings Overview
    Table: Pharmaceutical Business Environment Indicators
    Weighting
    Table: Weighting Of Components
    Sources
Skip to top


The Pharmaceutical Market: Cuba US$ 1,295.00 Mar, 2013
The Pharmaceutical Market: Czech Republic US$ 1,295.00 Jan, 2013 · 90 pages
The Pharmaceutical Market: Denmark US$ 1,295.00 Mar, 2013
The Pharmaceutical Market: Egypt US$ 1,295.00 Jan, 2013 · 111 pages

Ask Your Question

The Pharmaceutical Market: Indonesia
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: